| To Assess the Interaction Between Sunitinib and Ketoconazole to Reduce the Dose and Cost of Sunitinib (NCT01548170) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2011-04-01 |
| Effect of Zinc on Barrett's Metaplasia (NCT01984580) | Main Line Health | 2011-04-01 |
| A Safety Study Evaluating N6022 in Multiple-Ascending Doses in Healthy Subjects (NCT01339897) | Nivalis Therapeutics, Inc. | 2011-04-01 |
| A Study to Compare Oral Absorption of YM060 Between Orally-disintegrating Tablet (Without Water) and Conventional Tablet (NCT01392794) | Astellas Pharma Inc | 2011-04-01 |
| Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (NCT00892190) | University of Pittsburgh | 2011-04-01 |
| A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome. (NCT01236144) | Cardiff University | 2011-04-01 |
| Safety and Maximum Tolerated Dose (MTD) Study of INNO-206 in Subjects With Advanced Solid Tumors (NCT01337505) | ImmunityBio, Inc. | 2011-04-01 |
| Safety of Autologous MSC Infusion to Treat Epilepsy (NCT02497443) | Ministry of Public Health, Republic of Belarus | 2011-04-01 |
| Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted In The Evening or Immediately Following A 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers (NCT01321671) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-04-01 |
| Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus® /Pulmoaid® in Patients With Cystic Fibrosis (NCT01337219) | Erempharma | 2011-04-01 |
| A Dose Escalation Study of SCB01A in Subjects With Advanced Solid Tumors Who Have Failed Standard Therapy (NCT01159522) | SynCore Biotechnology Co., Ltd. | 2011-04-01 |
| Contrast- Enhanced Whole-Heart Coronary MRA at 3.0T (Tesla) (NCT02092428) | Cedars-Sinai Medical Center | 2011-04-01 |
| Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated (NCT01332721) | Tracon Pharmaceuticals Inc. | 2011-04-01 |
| Safety of Autologous Human Umbilical Cord Blood Mononuclear Fraction to Treat Acquired Hearing Loss in Children (NCT01343394) | Aryn Knight | 2011-04-01 |
| Safety and Feasibility of an Endotoxemia Model (NCT01329965) | Penn State University | 2011-04-01 |
| Effects of Administration of Fostamatinib on Blood Concentrations of Rifampicin in Healthy Subjects. (NCT01336218) | AstraZeneca | 2011-04-01 |
| Safety and Tolerability Study of Liquid Alpha1 Proteinase Inhibitor (API) in Subjects With Cystic Fibrosis (NCT01347190) | CSL Behring | 2011-04-01 |
| Drug Drug Interaction of BI 201335 and Tenofovir (NCT01340196) | Boehringer Ingelheim | 2011-04-01 |
| Dyad Oxytocin Study (DOS) (NCT02302209) | University of California, San Francisco | 2011-04-01 |
| Intraumbilical Misoprostol in Retained Placenta (NCT01840813) | Hawler Medical University | 2011-04-01 |
| Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy (NCT01332279) | Fox Chase Cancer Center | 2011-04-01 |
| NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors (NCT01324115) | Cancer Research UK | 2011-04-01 |
| A Bioavailability Study Comparing 3 Different AZD1981 Tablets (NCT01311635) | AstraZeneca | 2011-04-01 |
| Safety and Efficacy of the Addition of Alanyl-Glutamine-Dipeptide to Dialysis Solution in Peritoneal Dialysis (NCT01353638) | Christoph Aufricht | 2011-04-01 |
| CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation (NCT01336478) | Imperial College London | 2011-04-01 |
| Combined Single / Multiple Dose Escalation Study in Patients With Renal Anemia Due to CKD (Chronic Kidney Disease) (NCT01332942) | Bayer | 2011-04-01 |
| Paullinia Cupana for Anorexia in Oncologic Patients (NCT01540019) | Faculdade de Medicina do ABC | 2011-04-01 |
| Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet (NCT03517020) | Torrent Pharmaceuticals Limited | 2011-04-01 |
| Study of the Safety, Tolerability and Pharmacokinetics of Testosterone Undecanoate in Hypogonadal Males. (NCT01346319) | Abbott | 2011-04-01 |
| Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers (NCT01444677) | Yungjin Pharm. Co., Ltd. | 2011-04-01 |
| A Placebo-controlled Four Way Crossover Study to Asses the Effect of a Single Oral Dose of NKTR-118 on QTc Interval in Healthy Male Subjects (NCT01325415) | AstraZeneca | 2011-04-01 |
| Study of Tesetaxel in Japanese Patients With Solid Tumors (NCT01337310) | Genta Incorporated | 2011-04-01 |
| Exercise as Alcohol Use Disorders Intervention for Non-Treatment Seeking Adults (NCT01399554) | St. Louis University | 2011-04-01 |
| Cabazitaxel - PF Induction Chemotherapy (NCT01379339) | Krzysztof Misiukiewicz | 2011-04-01 |
| PK Comparisons of Bepotastine Besilate 10 mg and Bepotastine Salicylate 9.64 mg (NCT01897428) | Korea University Anam Hospital | 2011-04-01 |
| Ibudilast in the Treatment of Medication Overuse Headache (NCT01317992) | University of Adelaide | 2011-04-01 |
| A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid Tumors (NCT01240655) | Novartis Pharmaceuticals | 2011-04-01 |
| Clinical Study to Evaluate the Maximum Tolerated Dose of BAY87-2243 in Patients With Advanced Malignancies (NCT01297530) | Bayer | 2011-04-01 |
| Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps (NCT01350258) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2011-04-01 |
| A Study of LY2951742 in Healthy Volunteers (NCT01337596) | Eli Lilly and Company | 2011-04-01 |
| Safety Tolerability and Pharmacokinetic of BI 409306 (NCT01343706) | Boehringer Ingelheim | 2011-04-01 |
| A Study of RO5093151 in Patients With Non-Alcoholic Fatty Liver Disease (NCT01277094) | Hoffmann-La Roche | 2011-04-01 |
| Study to Compare Adhesiveness of Two Different Rotigotine Patch Formulations (NCT01338896) | UCB Pharma | 2011-04-01 |
| Absorption of Paracetamol, Talinolol and Amoxicillin After Oral Administration Using Non-caloric and Caloric Water (NCT01635608) | University Medicine Greifswald | 2011-04-01 |
| Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders (NCT01372228) | Talaris Therapeutics Inc. | 2011-04-01 |
| Pivotal Bioequivalence FDC Nifedipine / Candesartan vs. Loose Combination of Single Components, Fed (NCT01350609) | Bayer | 2011-04-01 |
| A Study Of Gastrointestinal Tolerability Of PF05212389 In Obese Subjects (NCT01472848) | Pfizer | 2011-04-01 |
| A Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy Secondary To Tractional Retinal Detachment in Proliferative Diabetic Retinopathy (NCT01487070) | Retina Institute of Hawaii | 2011-04-01 |
| A Study of Administration of Trastuzumab (Herceptin) by a Single-use Injection Device Versus a Handheld Syringe (NCT01344863) | Hoffmann-La Roche | 2011-04-01 |
| Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients (NCT01348100) | Novartis Pharmaceuticals | 2011-04-01 |
| Safety Study of Bone Marrow Cell Concentrate Prepared Using the Magellan System to Treat Critical Limb Ischemia (CLI) (NCT01386216) | Arteriocyte, Inc. | 2011-04-01 |
| Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed Condition (NCT01603186) | IPCA Laboratories Ltd. | 2011-04-01 |
| 1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG Refractory Superficial Bladder Cancer (NCT01162785) | M.D. Anderson Cancer Center | 2011-04-01 |
| CKD-828(80/2.5mg) Pharmacokinetic Study_2nd (NCT01352689) | Chong Kun Dang Pharmaceutical | 2011-04-01 |
| Antimicrobial Activity of IV Clear™ Dressing - Prevention of Antimicrobial Regrowth (NCT01368120) | Covalon Technologies Inc. | 2011-04-01 |
| A Study of JNS002 (Doxorubicin Hydrochloride Liposome Injection) in Relapsed or Refractory Multiple Myeloma (NCT01371227) | Janssen Pharmaceutical K.K. | 2011-04-01 |
| Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy Subjects (NCT01834742) | Norgine | 2011-04-01 |
| Study of the JAK Inhibitor Ruxolitinib Administered Orally to Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia-Myelofibrosis (PET-MF) (NCT01317875) | Incyte Corporation | 2011-03-31 |
| Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in Healthy Subjects (NCT02348372) | GlaxoSmithKline | 2011-03-31 |
| A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With Azithromycin (NCT01416350) | GlaxoSmithKline | 2011-03-30 |
| A Study of DS-2248 in Participants With Advanced Solid Tumors (NCT01288430) | Daiichi Sankyo | 2011-03-29 |
| GSK2239633 FTIH Study (NCT01371812) | GlaxoSmithKline | 2011-03-29 |
| A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT01254409) | Hoffmann-La Roche | 2011-03-29 |
| A Study to Assess Pharmacokinetics (PK) of Preladenant in Participants With Chronic Renal Impairment (CRI) (P06512) (NCT01323855) | Merck Sharp & Dohme LLC | 2011-03-28 |
| Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads (NCT01336985) | National Institutes of Health Clinical Center (CC) | 2011-03-28 |
| Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer (NCT01327781) | National Cancer Institute (NCI) | 2011-03-25 |
| Effects of Suvorexant in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032) (NCT01293006) | Merck Sharp & Dohme LLC | 2011-03-25 |
| Studying An Investigational Drug Crizotinib (PF-02341066) In Non Non-Small Cell Lung Cancer Tumors That Are Positive For Anaplastic Lymphoma Kinase (ALK) (NCT01121588) | Pfizer | 2011-03-22 |
| Bioequivalence Study of an Amoxicillin-Clavulanic (NCT01772238) | GlaxoSmithKline | 2011-03-22 |
| A Study of Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia and Polatuzumab Vedotin in Combination With Rituximab in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma (NCT01290549) | Genentech, Inc. | 2011-03-22 |
| Effects of Suvorexant in Participants With Obstructive Sleep Apnea (MK-4305-036) (NCT01300455) | Merck Sharp & Dohme LLC | 2011-03-19 |
| Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer (NCT01324141) | National Cancer Institute (NCI) | 2011-03-18 |
| Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients (NCT01309490) | Jewish General Hospital | 2011-03-17 |
| Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Oral WCK 2349 (NCT04874324) | Wockhardt | 2011-03-17 |
| A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer (NCT01296555) | Genentech, Inc. | 2011-03-16 |
| Single Dose Group Stratified Study in Renal Impaired and Healthy Aged and Gender Matched Subjects (NCT01318551) | Bayer | 2011-03-16 |
| Topical Sodium Nitrite for Chronic Leg Ulcers in Adult Patients With Blood Disorders (NCT01316796) | National Heart, Lung, and Blood Institute (NHLBI) | 2011-03-15 |
| BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer (NCT01314105) | Boehringer Ingelheim | 2011-03-15 |
| Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer (NCT01281852) | National Cancer Institute (NCI) | 2011-03-14 |
| Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone (NCT01428089) | University of Virginia | 2011-03-11 |
| Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects. (NCT01476046) | GlaxoSmithKline | 2011-03-08 |
| PK and Safety of Midostaurin in Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function (NCT01429337) | Novartis Pharmaceuticals | 2011-03-07 |
| Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001) (NCT01295827) | Merck Sharp & Dohme LLC | 2011-03-04 |
| Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum (NCT01313429) | National Cancer Institute (NCI) | 2011-03-04 |
| AZD8055 for Adults With Recurrent Gliomas (NCT01316809) | National Cancer Institute (NCI) | 2011-03-04 |
| Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors (NCT01292655) | Bristol-Myers Squibb | 2011-03-03 |
| Extension of Study HGT-SAN-055 Evaluating Administration of rhHNS in Patients With Sanfilippo Syndrome Type A (MPS IIIA) (NCT01299727) | Shire | 2011-03-01 |
| Safety, Pharmacokinetic, Pharmacodynamic Study of LAPS-IFNa in Healthy Adult Subjects (NCT01504581) | Hanmi Pharmaceutical Company Limited | 2011-03-01 |
| Safety and Efficacy Study of CENV3 Vaccine to Protect Against HCV Infection (NCT01718834) | National Liver Institute, Egypt | 2011-03-01 |
| An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196 (NCT01485952) | Siena Biotech S.p.A. | 2011-03-01 |
| Study to Assess Safety and Efficacy of Anti-Interleukin 6-receptor (IL6R) Nanobody in Rheumatoid Arthritis (RA) Patients (NCT01284569) | Ablynx, a Sanofi company | 2011-03-01 |
| Local Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young Volunteers (NCT01278784) | Medical University of Vienna | 2011-03-01 |
| Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis (NCT00867607) | Hadassah Medical Organization | 2011-03-01 |
| Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers (NCT01303445) | Boehringer Ingelheim | 2011-03-01 |
| Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects (NCT01459250) | Novartis Pharmaceuticals | 2011-03-01 |
| Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma (NCT01302613) | University of Texas Southwestern Medical Center | 2011-03-01 |
| Clinical Assessment of Safety and Tolerability of the New Monoclonal Humanized Antibody CaCP29 (NCT01319903) | InflaRx GmbH | 2011-03-01 |
| Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline (NCT00901823) | Essentialis, Inc. | 2011-03-01 |
| A Study to Determine the Pharmacodynamics of LX4211 Relative to Meals in Healthy Subjects (NCT01334242) | Lexicon Pharmaceuticals | 2011-03-01 |
| Three-way-cross-over Study to Evaluate Safety and Pharmacokinetics of Lacosamide in Healthy Japanese and Chinese Males (NCT01375387) | UCB Pharma | 2011-03-01 |